>Marché de la thérapie numérique (DTx) au Moyen-Orient et en Afrique, par type de produit et de service (produits matériels, solutions/logiciels, services), application (applications liées au traitement/aux soins, applications préventives), mode d'achat (organisation d'achat groupé, individuel), canal de vente (B2B, B2C), pays (Arabie saoudite, Afrique du Sud, Émirats arabes unis, Israël, Égypte, reste du Moyen-Orient et de l'Afrique) Tendances et prévisions de l'industrie jusqu'en 2028
Analyse et perspectives du marché : marché des thérapies numériques (DTx) au Moyen-Orient et en Afrique
Le marché thérapeutique numérique (DTx) devrait connaître une croissance de marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 23,4% au cours de la période de prévision de 2021 à 2028 et devrait atteindre 10 639,36 millions USD d'ici 2028. La prévalence croissante de maladies chroniques comme le diabète, l'hypertension entre autres ainsi que la sensibilisation croissante des agences gouvernementales augmenteront la croissance du marché thérapeutique numérique.
Les thérapies numériques (DTx) permettent d'offrir des interventions thérapeutiques directement aux patients à l'aide de logiciels fondés sur des données probantes et évalués à distance pour traiter, gérer et prévenir un large éventail de troubles comportementaux, mentaux et physiques. Elles sont utilisées seules ou en association avec des médicaments, des appareils ou d'autres thérapies pour optimiser les soins aux patients et les résultats de santé. L'accès à distance croissant à des thérapies cliniquement testées comme sûres et efficaces est l'une des propriétés des thérapies numériques (DTx) pendant le traitement.
Les progrès technologiques réalisés par les entreprises pour élargir leur gamme de produits et réaliser des bénéfices sont l'un des moteurs de la croissance du marché de la thérapie numérique (DTx). Les problèmes de confidentialité liés aux applications thérapeutiques numériques (DTx) peuvent constituer un frein à la croissance du marché de la thérapie numérique (DTx). La collaboration entre les entreprises contribuera à la croissance du marché et constituera une opportunité pour le marché de la thérapie numérique (DTx). La qualité de la thérapie numérique (DTx) doit être maintenue afin de fournir un meilleur traitement et des soins appropriés aux clients. Par conséquent, cela doit être fait correctement, ce qui constituerait un défi pour le marché de la thérapie numérique (DTx) car bien souvent, le besoin n'est pas satisfait.
Le rapport sur le marché de la thérapie numérique (DTx) fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché de la thérapie numérique (DTx), contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Middle East and Africa Digital Therapeutic (DTx) Market Scope and Market Size
The digital therapeutic (DTx) market is categorized into four segments which are based on product and service type, application, purchase mode and sales channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product and service type, the digital therapeutic (DTx) market is segmented into hardware products, solutions/software and service. In 2021, solutions/software segment is expected to dominate the market since with the pandemic situation going on the safety is the prime responsibility, therefore people would tend to prefer this segment and the prevailing diseases will increase the market.
- On the basis of application, the digital therapeutic (DTx) market is segmented into treatment/ care-related applications and preventive applications. In 2021, treatment/care-related applications segment is expected to dominate since this would provide treatment for the chronic disorders which are highly prevailing and the improved life style will tend to increase the market.
- On the basis of purchase mode, the digital therapeutic (DTx) market is segmented into group purchase organization and individual. In 2021, individual segment is expected to dominate the market since many people individually are accepting the digital healthcare platform and want to get treated without any contact and the initiatives taken by the government agencies will tend to increase the market.
- On the basis of sales channel, the digital therapeutic (DTx) market is segmented into B2B and B2C. In 2021, B2C segment is expected to dominate the market since the services are mostly preferred directly to the customers and hence increase the life style and let the market grow.
Digital Therapeutic (DTx) Market Country Level Analysis
The digital therapeutic (DTx) market is analysed and market size information is provided by the country, product and service type, application, purchase mode and sales channel as referenced above.
The countries covered in the digital therapeutic (DTx) market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt, and Rest of Middle East and Africa.
Middle East and Africa is expected to grow with the substantial growth rate in the forecast period of 2021 to 2028 as Middle East and Africa counties are major developing countries and focus on increasing usage of digital therapeutic (DTx) product and rising awareness about it. South Africa is expected to dominate in the market in the Middle East and Africa market due to increasing number of cases in diabetes.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by manufactures is Creating New Opportunities for Players in the Digital Therapeutic (DTx) Market
The digital therapeutic (DTx) market also provides you with detailed market analysis for every country growth in digital therapeutic (DTx) product sales, impact of advancement in the digital therapeutic (DTx) and changes in regulatory scenarios with their support for the digital therapeutic (DTx) market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Digital Therapeutic (DTx) Market Share Analysis
The digital therapeutic (DTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to digital therapeutic (DTx) market.
The major companies providing digital therapeutic (DTx) are Fitbit, Inc., ResMed, Omada Health, Inc., and Samsung among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the digital therapeutic (DTx) market.
For instance,
- In October 2020, TrialCard’s MANGO HEALTH announced a new interoperable technology platform and launched version 2.0 of Mango Health. This latest version includes third-party health service providers with turnkey access to Mango’s robust suite of patient support modules. The company will gain more new subscribers.
- In May 2019, CogniFit had done a study in which it had studied a general assessment that would provide adaptive learning using EEG. It would also help in the stimulation of brain areas of each cognitive skill. This helped the company to be a world leader in brain training and new technologies.
La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché des entreprises sur le marché thérapeutique numérique (DTx), ce qui offre également l'avantage aux organisations d'améliorer leur offre de thérapie numérique (DTx).
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
5.1.5 IMPROVED QUALITY OF LIFE
5.2 RESTRAINTS
5.2.1 PATIENT INFORMATION PRIVACY POLICIES
5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES
5.3 OPPORTUNITIES
5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS
5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
5.3.3 PARTNERSHIP BETWEEN COMPANIES
5.3.4 EXPANSION AND LAUNCH OF PRODUCTS
5.3.5 EVENTS AND EXHIBITION
5.3.6 PHYSICIAN ADOPTION
5.4 CHALLENGES
5.4.1 CLINICAL VALIDATION
5.4.2 REGULATORY APPROVAL
5.4.3 PAYER REIMBURSEMENT
6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
6.1 IMPACT ON DEMAND
6.2 IMPACT ON SUPPLY
6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19
6.4 CONCLUSION
7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
7.1 OVERVIEW
7.2 SOLUTION/SOFTWARE
7.3 HARDWARE PRODUCTS
7.4 SERVICE
8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 TREATMENT/CARE-RELATED APPLIACTIONS
8.2.1 DIABETES
8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
8.2.3 SMOKING CESSATION
8.2.4 CHRONIC RESPIRATORY DISEASES
8.2.5 MUSCULOSKELETAL DISORDER
8.2.6 CARDIOVASCULAR DISEASES
8.2.7 MEDICATION ADHERENCE
8.2.8 GASTROINTESTINAL DISORDERS
8.2.9 REHABILITATION AND PATIENT CARE
8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT
8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS
8.3 PREVENTIVE APPLICATIONS
8.3.1 PREDIABETES
8.3.2 OBESITY
8.3.3 NUTRITION
8.3.4 LIFESTYLE MANAGEMENT
8.3.5 OTHER PREVENTIVE APPLICATIONS
9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATION
9.2.1 SOLUTIONS/ SOFTWARE
9.2.2 HARDWARE PRODUCT
9.2.3 SERVICE
9.3 INDIVIDUAL
9.3.1 SOLUTIONS/ SOFTWARE
9.3.2 HARDWARE PRODUCT
9.3.3 SERVICE
10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
10.1 OVERVIEW
10.2 B2B
10.2.1 PAYERS
10.2.2 EMPLOYERS
10.2.3 PHARMA COMPANIES
10.2.4 PROVIDERS
10.2.5 OTHER BUYERS
10.3 B2C
10.3.1 CAREGIVERS
10.3.2 PATIENTS
11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY
11.1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY
11.1.1 SAUDI ARABIA
11.1.2 SOUTH AFRICA
11.1.3 UAE
11.1.4 ISRAEL
11.1.5 EGYPT
11.1.6 REST OF MIDDLE EAST & AFRICA
12 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 SWOT
14 COMPANY PROFILE
14.1 FITBIT,INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 LIVONGO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 OMADA HEALTH, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 GINGER
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 SAMSUNG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 MINDSTRONG HEALTH
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 2MORROW INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 AKILI INTERACTIVE LABS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ATENTIV
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 AYOGO HEALTH INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 BETTER THERAPEUTICS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 CANARY HEALTH
14.13.1 COMPANY SNAPSHOT
14.13.2 SOLUTION PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CLICK THERAPEUTICS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 COGNIFIT
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 COGNOA
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 GAIA AG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 HAPPIFY, INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 KAIA HEALTH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MANGO HEALTH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 NATURAL CYCLES USA CORP
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NOOM, INC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 PEAR THERAPEUTICS, INC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 SMARTPATIENT GMBH
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 VOLUNTIS
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENTS
14.26 WELLDOC, INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 WELLTHY THERAPEUTICS PVT LTD
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))
TABLE 4 MIDDLE EAST & AFRICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 32 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 33 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 34 SAUDI ARABIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 SAUDI ARABIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 37 SAUDI ARABIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 38 SAUDI ARABIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 39 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 SAUDI ARABIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 SAUDI ARABIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 UAE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 UAE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 57 UAE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 58 UAE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 59 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 UAE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 UAE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 67 ISRAEL GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 68 ISRAEL INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 69 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 ISRAEL B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 ISRAEL B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 72 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 73 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 EGYPT TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 EGYPT PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 77 EGYPT GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 EGYPT B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 EGYPT B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 82 REST OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.
FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 15 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020
FIGURE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)
FIGURE 18 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020
FIGURE 20 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020
FIGURE 24 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020
FIGURE 28 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 30 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)
FIGURE 32 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)
FIGURE 33 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)
FIGURE 36 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
